SEC Form 4 · accession 0000874015-16-000142
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C Frank Bennett
Officer — SVP, Antisense Research
Period of report
Nov 7, 2016
Accepted (ET)
Nov 9, 2016 · 6:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 7, 2016 | M | 5,000 | $11.27 | A | 15,803 | D | |
| Common StockF1 | Nov 7, 2016 | S | 5,000 | $34.00 | D | 10,803 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $11.27 | Nov 7, 2016 | M | 5,000 | D | Jan 4, 2014 | Jan 3, 2017 | Common Stock | 5,000 | 22,805 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option that was scheduled to expire on 1/3/17. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 9/16/17.